As per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that the Company has scheduled investor interaction through a teleconference call on Wednesday, 10 August 2022 at 2:00 pm (IST), post the announcement of unaudited financial results for the quarter ended 30 June 2022. Details for joining the call are attached.
The above information is a part of company’s filings submitted to BSE.